A. Araujo, I. Astrakhantseva, H. Fields, and S. Kamili, Distinguishing Acute from Chronic Hepatitis C Virus (HCV) Infection Based on Antibody Reactivities to Specific HCV Structural and Nonstructural Proteins, Journal of Clinical Microbiology, vol.49, issue.1, pp.54-57, 2011.
DOI : 10.1128/JCM.01064-10

C. Augustine, J. Yoo, A. Potti, Y. Yoshimoto, P. Zipfel et al., Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma, Clinical Cancer Research, vol.15, issue.2, pp.502-510, 2009.
DOI : 10.1158/1078-0432.CCR-08-1916

S. Bassett, K. Brasky, and R. Lanford, Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles, J Virol, vol.72, issue.4, pp.2589-2599, 1998.

S. Brillanti, C. Masci, P. Ricci, M. Miglioli, and L. Barbara, Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C, Hepatology, vol.115, issue.6, pp.998-1001, 1992.
DOI : 10.1002/hep.1840150604

Z. Chen and K. Weck, Hepatitis C Virus Genotyping: Interrogation of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1b, Journal of Clinical Microbiology, vol.40, issue.9, pp.3127-3134, 2002.
DOI : 10.1128/JCM.40.9.3127-3134.2002

M. Chen, M. Sallberg, A. Sonnerborg, O. Weiland, L. Mattsson et al., Limited humoral immunity in hepatitis C virus infection, Gastroenterology, vol.116, issue.1, pp.135-143, 1999.
DOI : 10.1016/S0016-5085(99)70237-4

J. Chen, H. Liu, Y. J. Chou, and K. , Prediction of linear B-cell epitopes using amino acid pair antigenicity scale, Amino Acids, vol.50, issue.3, pp.423-428, 2007.
DOI : 10.1007/s00726-006-0485-9

B. Cherif, A. Roget, C. Villiers, R. Calemczuk, V. Leroy et al., Clinically Related Protein-Peptide Interactions Monitored in Real Time on Novel Peptide Chips by Surface Plasmon Resonance Imaging, Clinical Chemistry, vol.52, issue.2, pp.255-262, 2006.
DOI : 10.1373/clinchem.2005.058727
URL : https://hal.archives-ouvertes.fr/inserm-00089356

I. Desombere, H. Van-vlierberghe, O. Weiland, C. Hultgren, M. Sallberg et al., Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C, Journal of Medical Virology, vol.25, issue.11, pp.701-713, 2007.
DOI : 10.1002/jmv.20846

E. Awady, M. , E. Abd, Y. Shoeb, H. Tabll et al., Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis, Virology Journal, vol.3, issue.1, p.67, 2006.
DOI : 10.1186/1743-422X-3-67

A. Gabrielli, Z. Zhang, G. Cherubini, M. Candela, S. Savoldi et al., Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia, Clinical and Experimental Immunology, vol.105, issue.1, pp.59-64, 1996.
DOI : 10.1046/j.1365-2249.1996.d01-720.x

E. Gane, G. Maertens, A. Ducatteeuw, K. Qian, J. Lau et al., ANTIBODIES TO HEPATITIS C VIRUS ENVELOPE PROTEINS CORRELATE WITH HEPATITIS C VIRAEMIA AFTER LIVER TRANSPLANTATION, Transplantation, vol.67, issue.1, pp.78-84, 1999.
DOI : 10.1097/00007890-199901150-00013

E. Giang, M. Dorner, J. Prentoe, M. Dreux, M. Evans et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus, Proceedings of the National Academy of Sciences, vol.109, issue.16, pp.6205-6210, 2012.
DOI : 10.1073/pnas.1114927109

T. Golub, D. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek et al., Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science, vol.286, issue.5439, pp.531-537, 1999.
DOI : 10.1126/science.286.5439.531

C. Gremion and A. Cerny, Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, vol.38, issue.4, pp.235-268, 2005.
DOI : 10.1002/rmv.466

J. Gutierrez, A. Klepper, J. Garber, J. Walewski, K. Bateman et al., Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid, Journal of Virological Methods, vol.171, issue.1, pp.169-175, 2011.
DOI : 10.1016/j.jviromet.2010.10.020

J. Hilfenhaus, U. Krupka, T. Nowak, L. Cummins, K. Fuchs et al., Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response, Journal of General Virology, vol.73, issue.4, pp.1015-1019, 1992.
DOI : 10.1099/0022-1317-73-4-1015

R. Hope and J. Mclauchlan, Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein, Journal of General Virology, vol.81, issue.8, pp.1913-1925, 2000.
DOI : 10.1099/0022-1317-81-8-1913

S. Hwang, M. Tong, P. Lai, E. Ko, R. Co et al., Evaluation of hepatitis B and C viral markers: clinical significance in asian and caucasian patients with hepatocellular carcinoma in the United states of America, J Gastroenterol Hepatol, vol.11, issue.10, pp.949-954, 1996.

M. Irshad, I. Khushboo, S. Singh, and S. Singh, Hepatitis C Virus (HCV): A Review of Immunological Aspects, International Reviews of Immunology, vol.42, issue.3, pp.497-517, 2008.
DOI : 10.1073/pnas.91.4.1294

K. Klein, S. Dellos, and J. Lingappa, Identification of Residues in the Hepatitis C Virus Core Protein That Are Critical for Capsid Assembly in a Cell-Free System, Journal of Virology, vol.79, issue.11, pp.6814-6826, 2005.
DOI : 10.1128/JVI.79.11.6814-6826.2005

M. Law, T. Maruyama, J. Lewis, E. Giang, A. Tarr et al., Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge, Nature Medicine, vol.78, issue.1, pp.25-27, 2008.
DOI : 10.1016/j.virol.2006.05.015

H. Lohr, C. Elste, H. Dienes, G. Michel, H. Braun et al., The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-??, Journal of Hepatology, vol.25, issue.3, pp.292-300, 1996.
DOI : 10.1016/S0168-8278(96)80114-0

P. Maksimov, J. Zerweck, A. Maksimov, A. Hotop, U. Gross et al., Peptide Microarray Analysis of In Silico-Predicted Epitopes for Serological Diagnosis of Toxoplasma gondii Infection in Humans, Clinical and Vaccine Immunology, vol.19, issue.6, pp.865-874, 2012.
DOI : 10.1128/CVI.00119-12

M. Nasoff, S. Zebedee, G. Inchauspe, and A. Prince, Identification of an immunodominant epitope within the capsid protein of hepatitis C virus., Proceedings of the National Academy of Sciences, vol.88, issue.12, pp.5462-5466, 1991.
DOI : 10.1073/pnas.88.12.5462

L. Nikolaeva, N. Blokhina, N. Tsurikova, N. Voronkova, M. Miminoshvili et al., Virus-specific antibody titres in different phases of hepatitis C virus infection, Journal of Viral Hepatitis, vol.44, issue.6, pp.429-437, 2002.
DOI : 10.1016/0140-6736(91)90942-I

J. Novotny, M. Handschumacher, E. Haber, R. Bruccoleri, W. Carlson et al., Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains)., Proceedings of the National Academy of Sciences, vol.83, issue.2, pp.226-230, 1986.
DOI : 10.1073/pnas.83.2.226

M. Perez-gordo, J. Lin, L. Bardina, C. Pastor-vargas, B. Cases et al., Epitope Mapping of Atlantic Salmon Major Allergen by Peptide Microarray Immunoassay, International Archives of Allergy and Immunology, vol.157, issue.1, pp.31-40, 2012.
DOI : 10.1159/000324677

M. Sallberg, U. Ruden, B. Wahren, and L. Magnius, Immunodominant regions within the hepatitis C virus core and putative matrix proteins, J Clin Microbiol, vol.30, issue.8, pp.1989-1994, 1992.

M. Sallberg, U. Ruden, B. Wahren, and L. Magnius, Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein, Clinical & Experimental Immunology, vol.73, issue.3, pp.489-494, 1993.
DOI : 10.1111/j.1365-2249.1993.tb05929.x

M. Sillanpaa, K. Melen, P. Porkka, R. Fagerlund, K. Nevalainen et al., Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection, Virology Journal, vol.6, issue.1, p.84, 2009.
DOI : 10.1186/1743-422X-6-84

J. Sollner, Selection and combination of machine learning classifiers for prediction of linear B-cell epitopes on proteins, Journal of Molecular Recognition, vol.19, issue.3, pp.209-214, 2006.
DOI : 10.1002/jmr.770

A. Sturn, J. Quackenbush, and Z. Trajanoski, Genesis: cluster analysis of microarray data, Bioinformatics, vol.18, issue.1, pp.207-208, 2002.
DOI : 10.1093/bioinformatics/18.1.207

. Van-'t, L. Veer, H. Dai, M. Van-de-vijver, Y. He et al., Expression profiling predicts outcome in breast cancer, Breast Cancer Res, vol.5, issue.1, pp.57-58, 2003.

M. Villiers, S. Cortes, C. Brakha, P. Marche, A. Roget et al., Polypyrrole???Peptide Microarray for Biomolecular Interaction Analysis by SPR Imaging, Methods Mol Biol, vol.570, pp.317-328, 2009.
DOI : 10.1007/978-1-60327-394-7_17
URL : https://hal.archives-ouvertes.fr/inserm-00415928

M. Villiers, S. Cortes, C. Brakha, J. Lavergne, C. Marquette et al., Peptide???protein microarrays and surface plasmon resonance detection: Biosensors for versatile biomolecular interaction analysis, Biosensors and Bioelectronics, vol.26, issue.4, pp.1554-1559, 2010.
DOI : 10.1016/j.bios.2010.07.110
URL : https://hal.archives-ouvertes.fr/hal-00916635

M. Villiers, C. Brakha, A. Buhot, C. Marquette, and P. Marche, Stability of Peptide in Microarrays: A Challenge for High-Throughput Screening, pp.199-214, 2011.
DOI : 10.5772/30309

N. Yuki, N. Hayashi, A. Kasahara, H. Hagiwara, K. Ohkawa et al., Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins, Hepatology, vol.341, issue.6, pp.1360-1365, 1994.
DOI : 10.1002/hep.1840190607

N. Yuki, N. Hayashi, A. Kasahara, H. Hagiwara, E. Mita et al., Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection, Hepatology, vol.23, issue.5, pp.947-952, 1996.
DOI : 10.1002/hep.510230501

N. Zein, The epidemiology and natural history of hepatitis C virus infection., Cleveland Clinic Journal of Medicine, vol.70, issue.Suppl_4, pp.2-6, 2003.
DOI : 10.3949/ccjm.70.Suppl_4.S2

H. Zhao, B. Ljungberg, K. Grankvist, T. Rasmuson, R. Tibshirani et al., Gene expression profiling predicts survival in conventional renal cell carcinoma Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection, PLoS Med J Hepatol, vol.3, issue.302, pp.177-184, 1999.